Lab
Dayton Pain Center LLC
Dayton Pain Center LLC was paid $2.05M by Medicaid between Mar 2018 and Nov 2024, across 28 billing codes. Its largest line is 80307, Drug test(s), presumptive, any number of drug classes; immunoassay — 38% of everything it billed.
33Billing provider infoDAYTON PAIN CENTER LLC
DAYTON, OH 45417
DAYTON, OH 45417
33aNPI1114425535assigned 01/31/2018
33bProvider typeClinical Medical Laboratory
28Total paid$2.05M
24GClaims125,610
24DCodes billed28
24AFirst – last monthMar 2018 – Nov 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Ohio
Rank by total paid#33 of 116
Median peer was paid$313K
This provider vs. median6.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 57,014 | $419K | |
| 2019 | 38,750 | $441K | |
| 2020 | 10,949 | $323K | |
| 2021 | 5,705 | $272K | |
| 2022 | 5,999 | $272K | |
| 2023 | 5,506 | $241K | |
| 2024incomplete | 1,687 | $82K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 38% | 25,300 | 13,587 | $773K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 23% | 4,467 | 4,107 | $474K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 7.9% | 1,877 | 1,745 | $161K |
| 80346 | 2.2% | 4,244 | 3,268 | $46K | |
| 83992 | 2.1% | 4,248 | 3,270 | $44K | |
| 80361 | 2.0% | 4,247 | 3,270 | $40K | |
| 80362 | 2.0% | 4,248 | 3,270 | $40K | |
| 80349 | 1.4% | 4,248 | 3,270 | $28K | |
| 80365 | 1.4% | 4,247 | 3,270 | $28K | |
| 80373 | 1.4% | 4,247 | 3,270 | $28K | |
| 80372 | 1.4% | 4,246 | 3,269 | $28K | |
| 80356 | 1.4% | 4,245 | 3,269 | $28K |
16 more codes
| 80336 | 1.4% | 4,245 | $28K | |
| 80354 | 1.4% | 4,245 | $28K | |
| 80348 | 1.4% | 4,243 | $28K | |
| 80324 | 1.4% | 4,241 | $28K | |
| 80368 | 1.3% | 4,245 | $28K | |
| 80366 | 1.3% | 4,246 | $27K | |
| 80359 | 1.1% | 4,247 | $23K | |
| 80358 | 1.1% | 4,246 | $23K | |
| 80353 | 1.1% | 4,245 | $23K | |
| 80355 | 1.1% | 4,245 | $23K | |
| 80360 | 1.1% | 4,244 | $23K | |
| 80369 | 1.1% | 4,242 | $23K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 1,257 | $16K |
| 80305 | <1% | 2,039 | $14K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 53 | $146.16 |
| 80335 | <1% | 1,463 | $15.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGOODWIN, ROBERT (PRACTICE MANAGER)
| Provider | Location | Paid |
|---|---|---|
| Dayton Pain Center LLC | Dayton, OH | $6.08M |
| Goodwin Chiropractic LLC | Dayton, OH | $1K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.